Clinical data | |
---|---|
Trade names | Dormonoct, Havlane, Sonin, Somnovit, others |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 6–12 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.293.781 |
Chemical and physical data | |
Formula | C23H21ClN6O3 |
Molar mass | 464.91 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Loprazolam (triazulenone) marketed under many brand names is a benzodiazepine medication. It possesses anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is licensed and marketed for the short-term treatment of moderately-severe insomnia.
It was patented in 1975 and came into medical use in 1983.[2]